Tehran University of Medical Sciences

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):
Faculty Members have conducted research related to the Covid-19 and Dermatology in Iran
Hamid Reza Mahmoodi
Hamid Reza Mahmoodi

Associate Professor of Dermatology

Department Dermatology

School of Medicine

Razi Hospital

Autoimmune Bullous Diseases Research Center

Tehran University of Medical Sciences

Related Documents
1. Covid-19: The Experience From Iran, Clinics in Dermatology (2021)
All Documents
1. Are Sites of Primary Lesions in Pemphigus Vulgaris More Prone to Relapse?, Oral Diseases (2024)
2. Dna Repair-Related Heritable Photosensitivity Syndromes: Mutation Landscape in a Multiethnic Cohort of 17 Multigenerational Families With High Degree of Consanguinity, DNA Repair (2024)
3. What Is Novel in the Clinical Management of Pemphigus Vulgaris?, Expert Review of Clinical Pharmacology (2024)
4. Anatomic Evaluation of the Normal Variants of the Arteries of Face Using Color Doppler Ultrasonography: Implications for Facial Aesthetic Procedures, Journal of Cosmetic Dermatology (2023)
5. Assessing the Risk of Anxiety in Patients With Pemphigus Vulgaris Using Beck Anxiety Inventory, Journal of Cosmetic Dermatology (2023)
6. Clinicopathological Characteristics of Bowen Disease: A 7-Year Study at a Referral Dermatology Hospital, Dermatology Practical and Conceptual (2023)
7. Comparing the Efficacy of Plasma Exeresis and Cryotherapy for the Treatment of Seborrheic Keratosis: A Randomized Controlled Trial, Skin Research and Technology (2023)
8. Dermoscopy of Cutaneous Granulomatous Disorders: A Study of 107 Cases, Skin Research and Technology (2023)
9. Detection of Herpes Simplex Viruses in the Oral Lesions of Patients With Pemphigus Vulgaris: Is It Diagnostic or Predictive of Disease Severity?, Skin Health and Disease (2023)
10. Drug Adherence and Its Association With Health Literacy Among Patients With Autoimmune Bullous Diseases, Journal of Clinical and Aesthetic Dermatology (2023)
11. Drug-Induced Cutaneous Pseudolymphoma: A Systematic Review of the Literature, Australasian Journal of Dermatology (2023)
12. Editorial: Challenges of Covid-19 in Dermatology Patients on Immunosuppression: Risk, Outcome, Vaccination and Beyond, Volume Ii, Frontiers in Medicine (2023)
13. Elevated Serum Level of B-Cell Activating Factor (Baff) After Rituximab Therapy in Pemphigus Vulgaris Patients Suggests a Possible Therapeutic Efficacy of B-Cell Depletion Therapies Combined With Anti-Baff Agents, International Journal of Dermatology (2023)
14. Factors Associated With the Healing Time of Pemphigus Vulgaris Oral Lesions: A Prospective Study, Oral Diseases (2023)
15. Infections in Hospitalized Patients With Psoriasis in a Skin Referral Hospital, Dermatology Practical and Conceptual (2023)
16. Nail Abnormalities in Subepidermal Blistering Diseases: A Cross-Sectional Study, International Journal of Dermatology (2023)
17. Odss Vs. Absis and Pdai Oral Parts in Pemphigus Vulgaris: Inter-Rater Reliability and Testing Times, Oral Diseases (2023)
18. Pemphigus Disease and Area Index: Unmet Needs in the Real-World Management of Pemphigus, Oral Diseases (2023)
19. Pilomatricoma: Histopathologic Evaluation of 100 Cases and Introduction of New Features, Iranian Journal of Dermatology (2023)
20. Rituximab for the Treatment of Epidermolysis Bullosa Acquisita: A Large Case Series of 15 Patients, JDDG - Journal of the German Society of Dermatology (2023)
21. Rituximab Zur Behandlung Von Epidermolysis Bullosa Acquisita: Eine Große Fallserie Mit 15 Patienten, JDDG - Journal of the German Society of Dermatology (2023)
22. Squamous Cell Carcinoma (Scc) and Intraepithelial Neoplasia Among Patients Diagnosed With Erosive Lichen Planus (Lp): A Study of 130 Patients, Australasian Journal of Dermatology (2023)
23. The Potential of Circulating Mir-193B, Mir-146B-3P and Mir-483-3P As Noninvasive Biomarkers in Cutaneous Melanoma Patients, Molecular Biotechnology (2023)
24. Treatment of Persistent Chemotherapy-Induced Hair Loss (Alopecia) With Human Mesenchymal Stromal Cells Exosome Enriched Extracellular Vesicles: A Case Report, Heliyon (2023)
25. Treatment Resistance to Tnf- Α Inhibitors in Patients With Psoriasis, Dermatologic Therapy (2023)
26. Whole Transcriptome-Based Skin Virome Profiling in Typical Epidermodysplasia Verruciformis Reveals Α-, Β-, and Γ-Hpv Infections, JCI Insight (2023)
27. A Young Boy With Brittle Hair, Case Reports in Dermatology (2022)
28. Adverse Outcome and Severity of Covid-19 in Patients With Autoimmune Bullous Diseases: A Historical Cohort Study, Dermatologic Therapy (2022)
29. Assessment of Health-Related Quality of Life in Patients With Frontal Fibrosing Alopecia, Journal of Cosmetic Dermatology (2022)
30. Botulinum Toxin Injection As a Single or Combined Treatment With Non-Cross-Linked High Molecular Weight and Low Molecular Weight Hyaluronic Acid Gel for Neck Rejuvenation: A Randomized Clinical Trial, Dermatologic Therapy (2022)
31. Burden of Pemphigus Vulgaris With a Particular Focus on Women: A Review, International Journal of Women's Dermatology (2022)
32. Clinical Characteristics and Treatment Outcomes of Scleromyxedema: A 10-Year Retrospective Survey, Case Reports in Dermatology (2022)
33. Comparing Efficacy and Safety of Potassium Hydroxide 5% Solution With 5-Fluorouracil Cream in Patients With Actinic Keratoses: A Randomized Controlled Trial, Journal of Dermatological Treatment (2022)
34. Comparison of the Efficacy and Safety of 308-Nm Excimer Laser With Intralesional Corticosteroids for the Treatment of Alopecia Areata: A Randomized Controlled Study, Lasers in Surgery and Medicine (2022)
35. Demographic and Clinical Characteristics of Hospitalized Psoriasis Patients, Journal of Cosmetic Dermatology (2022)
36. Dermoscopic Changes in Melanocytic Nevi Following Hair Removal Laser: A Prospective Study, Journal of Cosmetic Dermatology (2022)
37. Editorial: Challenges of Covid-19 in Dermatology Patients on Immunosuppression: Risk, Outcome, Vaccination, and Beyond, Frontiers in Medicine (2022)
38. Evaluating the Risk-To-Benefit Ratio of Using Cotrimoxazole As a Pneumocystis Pneumonia Preventative Intervention Among Pemphigus Patients Treated With Rituximab: A Retrospective Study With 494 Patients, Dermatologic Therapy (2022)
39. Exacerbation of Autoimmune Bullous Diseases After Severe Acute Respiratory Syndrome Coronavirus 2 Vaccination: Is There Any Association?, Frontiers in Medicine (2022)
40. Ichthyosis Follicularis Syndromes in Patients With Mutations in Gjb2, Clinical and Experimental Dermatology (2022)
41. Ichthyosis, Psoriasiform Dermatitis, and Recurrent Fungal Infections in Patients With Biallelic Mutations in Perp, Journal of the European Academy of Dermatology and Venereology (2022)
42. Lichen Planopilaris: Histopathological Survey of 70 Vertical Sections of Scalp Biopsies, Iranian Journal of Dermatology (2022)
43. Multiple Cycles of Rituximab Therapy for Pemphigus: A Group of Patients With Difficult- To-Treat Disease or a Consequence of Late Rituximab Initiation?, Dermatologic Therapy (2022)
44. Mutation Update: The Spectra of Plec Sequence Variants and Related Plectinopathies, Human Mutation (2022)
45. Novel Variants of Dock8 Deficiency in a Case Series of Iranian Patients, Endocrine# Metabolic and Immune Disorders - Drug Targets (2022)
46. Oral Isotretinoin Combined With Topical Clobetasol 0.05% and Tacrolimus 0.1% for the Treatment of Frontal Fibrosing Alopecia: A Randomized Controlled Trial, Journal of Dermatological Treatment (2022)
47. Pregnancy Outcomes in Women With Pemphigus Exposed to Rituximab Before or During Pregnancy, International Journal of Women's Dermatology (2022)
48. Prevalence and Management of Chronic Hepatitis B in Pemphigus and Pemphigoid Patients: New Evidence for the Safety of Rituximab, Dermatologic Therapy (2022)
49. Pustular Eruption After Biosimilar Rituximab Infusion: Report of Acute Generalized Exanthematous Pustulosis in Two Patients With Pemphigus, International Journal of Dermatology (2022)
50. Recalcitrant Cutaneous Warts in a Family With Inherited Icos Deficiency, Journal of Investigative Dermatology (2022)
51. Recurrent Aphthous Stomatitis, Diseases of the Oral Mucosa: Study Guide and Review (2022)
52. Retrospective Study of Gingival Involvement in Pemphigus: A Difficult to Treat Phenomenon, Dermatologic Therapy (2022)
53. Rituximab Monotherapy in Mild Pemphigus, Journal of Dermatological Treatment (2022)
54. Self-Assessment Pemphigus Vulgaris Activity Score (Sa-Pvas): A New Tool for Patients to Self-Assess Their Disease Severity, Australasian Journal of Dermatology (2022)
55. Stigma Experience in Patients With Vitiligo: A Comprehensive Study in a Skin Hospital, Acta Medica Iranica (2022)
56. The Efficacy of Rituximab in Patients With Mucous Membrane Pemphigoid, Journal of Dermatological Treatment (2022)
57. Treatment of Chronic Venous Ulcer With Cold Atmospheric Plasma Jet, Case Reports in Dermatology (2022)
58. Whole-Transcriptome Sequencing–Based Concomitant Detection of Viral and Human Genetic Determinants of Cutaneous Lesions, JCI Insight (2022)
59. Whole-Transcriptome Sequencing–Based Concomitant Detection of Viral and Human Genetic Determinants of Cutaneous Lesions, JCI Insight (2022)
60. A Systematic Review on Efficacy, Safety, and Treatment-Durability of Low-Dose Rituximab for the Treatment of Pemphigus: Special Focus on Covid-19 Pandemic Concerns, Immunopharmacology and Immunotoxicology (2021)
61. Characteristics and Outcomes of Covid-19 in Patients With Autoimmune Bullous Diseases: A Retrospective Cohort Study, Journal of the American Academy of Dermatology (2021)
62. Chronic Subungual Lesion in a Young Woman, Indian Journal of Dermatology# Venereology and Leprology (2021)
63. Clinical and Dermatoscopic Characteristics of Lichen Planus-Like Keratosis in a West-Asian Population, Australasian Journal of Dermatology (2021)
64. Comparing Qs Nd:Yag Laser Alone With Its Combination With Fractional Ablative Er:Yag in Tattoo Removal, Journal of Cosmetic Dermatology (2021)
65. Correlation of Anti-Γ/Ε Nicotinic Acetylcholine Receptor Antibody Levels With Anti-Desmoglein 1,3 Antibody Levels and Disease Severity in Pemphigus Vulgaris, Clinical and Experimental Dermatology (2021)
66. Covid-19: The Experience From Iran, Clinics in Dermatology (2021)
67. Current Status and Prospects for the Diagnosis of Pemphigus Vulgaris, Expert Review of Clinical Immunology (2021)
68. Dermoscopic Evaluation of Longitudinal Melanonychia in Children: A Prospective Study, Indian Journal of Dermatology (2021)
69. Does Double-Pass Pulsed-Dye Laser With Long and Short Pulse Duration Increase Treatment Efficacy of Port-Wine Stain? a Randomized Clinical Trial, Dermatologic Surgery (2021)
70. Drug-Induced Pemphigus: A Systematic Review of 170 Patients, International Immunopharmacology (2021)
71. Efficacy and Safety of Biosimilar Rituximab in Patients With Pemphigus Vulgaris: A Prospective Observational Study, Journal of Dermatological Treatment (2021)
72. Efficacy and Safety of Hydrogen Peroxide Topical Solution in Treating Actinic Keratosis: A Randomized Controlled Trial, Dermatologic Therapy (2021)
73. Epidermolysis Bullosa Acquisita: The Most Frequent Pemphigoid Disease in Patients With Dermal Binding Autoantibodies by Indirect Immunofluorescence Microscopy on Human Salt-Split Skin in Tehran, Iran, Journal of the European Academy of Dermatology and Venereology (2021)
74. Evaluating the Efficacy and Safety of Topical Sirolimus 0.2% Cream As Adjuvant Therapy With Pulsed Dye Laser for the Treatment of Port Wine Stain: A Randomized, Double-Blind, Placebo-Controlled Trial, Journal of Cosmetic Dermatology (2021)
75. Generalized Milia-Like Calcinosis Cutis in a Child With Down Syndrome: Dermoscopic Features, Dermatology Online Journal (2021)
76. Homozygous Mefv Gene Variant and Pyrin-Associated Autoinflammation With Neutrophilic Dermatosis: A Family With a Novel Autosomal Recessive Mode of Inheritance, JAMA Dermatology (2021)
77. Lichen Planus-Like Lesions in 36 Patients With Pemphigus: A Cross-Sectional Study, Oral Diseases (2021)
78. Metabolic Syndrome in Patients With Oral Lichen Planus and Lichen Planopilaris: A Cross-Sectional Study, Iranian Journal of Dermatology (2021)
79. Oral Simvastatin Combined With Narrowband Uvb for the Treatment of Psoriasis: A Randomized Controlled Trial, Dermatologic Therapy (2021)
80. Paradoxical Worsening of Pemphigus After Rituximab Presenting As Figurate Bullous Eruption, British Journal of Dermatology (2021)
81. Patchy Alopecia in a Patient With Rheumatoid Arthritis: A Practical Application of Trichoscopy, Case Reports in Dermatology (2021)
82. Rituximab Administration in Coronavirus Pandemic Era: A Mini-Review of Clinical Evidence, Journal of Iranian Medical Council (2021)
83. Rituximab in Practice: Clinical Evaluation of Patients With Pemphigus After Rituximab Administration, Dermatologic Therapy (2021)
84. The Evaluation of Efficacy of Atmospheric Pressure Plasma in Diabetic Ulcers Healing: A Randomized Clinical Trial, Dermatologic Therapy (2021)
85. Thermal Therapy With Radiofrequency for the Treatment of Basal Cell Carcinoma: A Pilot Study, Iranian Journal of Dermatology (2021)
86. Whole-Transcriptome Analysis by Rna Sequencing for Genetic Diagnosis of Mendelian Skin Disorders in the Context of Consanguinity, Clinical Chemistry (2021)
87. Acute Generalized Exanthematous Pustulosis With a Focus on Hydroxychloroquine: A 10-Year Experience in a Skin Hospital, International Immunopharmacology (2020)
88. An Enlarging Scaly Plaque Localized on the Previous Keloid of the Chest, Clinical Case Reports (2020)
89. Autoimmune Bullous Disease Quality of Life (Abqol) Questionnaire: Validation of the Translated Persian Version in Pemphigus Vulgaris, International Journal of Women's Dermatology (2020)
90. Comparison of Topical Nanocolloidal Silver Formulation Use With Eosin 2% Solution in Management of Hard-To-Heal Ulcers in Patients With Pemphigus Vulgaris, Journal of Wound Care (2020)
91. Concomitant Bullous Pemphigoid and Palmoplantar Keratoderma: A Report of Three Cases and Review of Literature, Dermatologic Therapy (2020)
92. Desquamative Gingivitis in a Pemphigus Vulgaris Patient Resistant to Rituximab, Dermatologic Therapy (2020)
93. Estimated Cut-Off Values for Pemphigus Severity Classification According to Pemphigus Disease Area Index (Pdai), Autoimmune Bullous Skin Disorder Intensity Score (Absis), and Anti-Desmoglein 1 Autoantibodies, BMC Dermatology (2020)
94. Family Impact of Pemphigus Disease in an Iranian Population Using the Family Dermatology Life Quality Index, International Journal of Women's Dermatology (2020)
95. Intralesional Injection of Biosimilar Rituximab in Recalcitrant Mucocutaneous Lesions of Patients With Pemphigus Vulgaris: A Pilot Study, Dermatologic Therapy (2020)
96. Investigating Expression Pattern of Eight Immune-Related Genes in Pemphigus Patients Compared With the Healthy Controls and After Rituximab Therapy: Potential Roles of Ctla4 and Fcgr3a Genes Expression in Outcomes of Rituximab Therapy, Dermatologic Therapy (2020)
97. Keratitis-Ichthyosis-Deafness Syndrome: Phenotypic Heterogeneity and Treatment Perspective of Patients With P.Asp50asn Gjb2 Mutation, Dermatologic Therapy (2020)
98. Multiple Giant Milia in Cutaneous Squamous Cell Carcinoma: A Rare Presentation, Australasian Journal of Dermatology (2020)
99. Paradoxical Reaction to Rituximab in Patients With Pemphigus: A Report of 10 Cases, Immunopharmacology and Immunotoxicology (2020)
100. Pathogenic and Protective Roles of Cytokines in Pemphigus: A Systematic Review, Cytokine (2020)
101. Quality of Life and Mental Health Status in Patients With Lichen Planopilaris Based on Dermatology Life Quality Index and General Health Questionnaire-28 Questionnaires, International Journal of Women's Dermatology (2020)
102. Remdesivir: A Beacon of Hope From Ebola Virus Disease to Covid-19, Reviews in Medical Virology (2020)
103. Rituximab in Childhood and Juvenile Autoimmune Bullous Diseases As First-Line and Second-Line Treatment: A Case Series of 13 Patients, Journal of Dermatological Treatment (2020)
104. Single-Nucleotide Polymorphisms Associated With Pemphigus Vulgaris: Potent Markers for Better Treatment and Personalized Medicine, International Journal of Immunogenetics (2020)
105. Successful Treatment of a Patient With Multicolored Nevus of Ota Using a Combination of 1064 and 532 Nm Q-Switched Nd:Yag Lasers, Journal of Cosmetic and Laser Therapy (2020)
106. Switching From Pemphigus Vulgaris to Psoriasis: A Rare Report of Three Cases, International Journal of Dermatology (2020)
107. Transition Between Pemphigus Vulgaris and Pemphigus Foliaceus: A 10-Year Follow-Up Study, JDDG - Journal of the German Society of Dermatology (2020)
108. Treatment of Pemphigus Patients in the Covid-19 Era: A Specific Focus on Rituximab, Dermatologic Therapy (2020)
109. A Case of Hidroacanthoma Simplex With New Dermoscopic Features, Indian Journal of Dermatology# Venereology and Leprology (2019)
110. A Case of Lepromatous Leprosy Clinically Masquerading As Vasculitis, Dermatology Practical and Conceptual (2019)
111. A Novel Autosomal Recessive Gjb2-Associated Disorder: Ichthyosis Follicularis, Bilateral Severe Sensorineural Hearing Loss, and Punctate Palmoplantar Keratoderma, Human Mutation (2019)
112. Angina Bullosa Haemorrhagica-Like Lesions in Pemphigus Vulgaris, Australasian Journal of Dermatology (2019)
113. Annular Lichenoid Dermatitis of Youth: Report on Two Adult Cases and One Child, JDDG - Journal of the German Society of Dermatology (2019)
114. Assessing the Correlation Between Trichoscopic Features in Lichen Planopilaris and Lichen Planopilaris Activity Index, Australasian Journal of Dermatology (2019)
115. Autosomal Recessive Congenital Ichthyosis: Genomic Landscape and Phenotypic Spectrum in a Cohort of 125 Consanguineous Families, Human Mutation (2019)
116. Biallelic Krt5 Mutations in Autosomal Recessive Epidermolysis Bullosa Simplex, Including a Complete Human Keratin 5 “Knock-Out”, Matrix Biology (2019)
117. Bulloses Pemphigoid Mit Linearen Lasionen Und Antikorpern Ausschließlich Gegen Die Losliche Ektodomane Von Bp180 (Lad-1), JDDG - Journal of the German Society of Dermatology (2019)
118. Bullous Pemphigoid With Linear Lesions and Antibodies Exclusively Against the Soluble Ectodomain of Bp180 (Lad-1), JDDG - Journal of the German Society of Dermatology (2019)
119. Comparing Early and Late Treatments With Rituximab in Pemphigus Vulgaris: Which One Is Better?, Archives of Dermatological Research (2019)
120. Effects of L-Carnitine Supplementation on Cardiovascular and Bone Turnover Markers in Patients With Pemphigus Vulgaris Under Corticosteroids Treatment: A Randomized, Double-Blind, Controlled Trial, Dermatologic Therapy (2019)
121. Effects of L-Carnitine Supplementation on Cardiovascular and Bone Turnover Markers in Patients With Pemphigus Vulgaris Under Corticosteroids Treatment: A Randomized, Double-Blind, Controlled Trial, Dermatologic Therapy (2019)
122. Epidermodysplasia Verruciformis: Genetic Heterogeneity and Ever1 and Ever2 Mutations Revealed by Genome-Wide Analysis, Journal of Investigative Dermatology (2019)
123. Frontal Fibrosing Alopecia: An Update on the Hypothesis of Pathogenesis and Treatment, International Journal of Women's Dermatology (2019)
124. Genome-Wide Single Nucleotide Polymorphism-Based Autozygosity Mapping Facilitates Identification of Mutations in Consanguineous Families With Epidermolysis Bullosa, Experimental Dermatology (2019)
125. Inter-Rater Reliability of the Biochip Indirect Immunofluorescence Dermatology Mosaic in Bullous Pemphigoid and Pemphigus Patients, Journal of the European Academy of Dermatology and Venereology (2019)
126. Iranian Guideline for Rituximab Therapy in Pemphigus Patients, Dermatologic Therapy (2019)
127. Lichen Planopilaris: Retrospective Study on the Characteristics and Treatment of 291 Patients, Journal of Dermatological Treatment (2019)
128. Otophyma in a Woman: A Rare and Neglected Clinicopathological Entity, Australasian Journal of Dermatology (2019)
129. Post-Orf Epidermolysis Bullosa Acquisita, Journal of the European Academy of Dermatology and Venereology (2019)
130. Reply To: “Comment on ‘Trichloroacetic Acid As a Treatment for Persistent Oral Mucosal Lesions in Pemphigus Vulgaris'”, Journal of the American Academy of Dermatology (2019)
131. Short-Term Clinical and Serological Follow-Up With Conventional and Conformational Anti-Desmoglein Antibodies in Treatment-Naive and Previously Treated Patients With Pemphigus Vulgaris After Receiving Rituximab, International Journal of Women's Dermatology (2019)
132. Treatment of Port Wine Stains With 595-Nm Pulsed Dye Laser in 27 Pediatric Patients: A Prospective Study in the Iranian Population, Journal of Cosmetic and Laser Therapy (2019)
133. Trichloroacetic Acid As a Treatment for Persistent Oral Mucosal Lesions in Pemphigus Vulgaris, Journal of the American Academy of Dermatology (2019)
134. Unexpected Worsening of Pemphigus Vulgaris After Rituximab: A Report of Three Cases, International Immunopharmacology (2019)
135. “Change Over Time in the Treatment of Pemphigus Vulgaris Between 2004 and 2016 in Iran”: A Multiple Cross-Sectional Study, Dermatologic Therapy (2019)
136. Annular Asymptomatic Plaques in a Diabetic Boy, Journal of Iranian Medical Council (2018)
137. Anti-Desmoglein-1 Levels As Predictor of Prednisolone Tapering in Pemphigus Vulgaris Patients Treated With Rituximab, Dermatologic Therapy (2018)
138. Bpdai and Absis Correlate With Serum Anti-Bp180 Nc16a Igg But Not With Anti-Bp230 Igg in Patients With Bullous Pemphigoid, Archives of Dermatological Research (2018)
139. Clinicoepidemiological Features of 82 Cases of Bullous Pemphigoid in Tehran, Iran, Acta Medica Iranica (2018)
140. Coexistence of Oral Lichen Planus and Pemphigus Vulgaris, Clinical Oral Investigations (2018)
141. Comparison of Ethylenediaminetetraacetic Acid-Treated Desmoglein Elisa and Conventional Desmoglein Elisa in the Evaluation of Pemphigus Vulgaris in Remission, Journal of the American Academy of Dermatology (2018)
142. Comparison of Intralesional Verapamil Versus Intralesional Corticosteroids in Treatment of Keloids and Hypertrophic Scars: A Randomized Controlled Trial, Burns (2018)
143. Cryotherapy Plus Oral Zinc Sulfate Versus Cryotherapy Plus Placebo to Treat Common Warts: A Double Blind, Randomized, Placebo-Controlled Trial, International Journal of Women's Dermatology (2018)
144. Dermoscopic Findings in 126 Patients With Alopecia Areata: A Cross-Sectional Study, International Journal of Trichology (2018)
145. Oral Candida Colonization and Plaque Type Psoriasis: Is There Any Relationship?, Journal of investigative and clinical dentistry (2018)
146. Recessive Mutation in Tetraspanin Cd151 Causes Kindler Syndrome-Like Epidermolysis Bullosa With Multi-Systemic Manifestations Including Nephropathy, Matrix Biology (2018)
147. Sixteen-Year History of Rituximab Therapy for 1085 Pemphigus Vulgaris Patients: A Systematic Review, International Immunopharmacology (2018)
148. Treatment of Basal Cell Carcinoma: Is Intralesional Methotrexate an Option?, Journal of Dermatological Treatment (2018)
149. Ulcerated Necrobiosis Lipoidica: A Cutaneous Granulomatous Reaction Associated With Systemic B-Cell Lymphoma, Indian Journal of Dermatology# Venereology and Leprology (2018)
150. Autosomal Recessive Congenital Ichthyosis: Cers3 Mutations Identified by a Next Generation Sequencing Panel Targeting Ichthyosis Genes, European Journal of Human Genetics (2017)
151. Multigene Next-Generation Sequencing Panel Identifies Pathogenic Variants in Patients With Unknown Subtype of Epidermolysis Bullosa: Subclassification With Prognostic Implications, Journal of Investigative Dermatology (2017)
152. Neurological Diseases and Bullous Pemphigoid: A Case-Control Study in Iranian Patients, Indian Journal of Dermatology# Venereology and Leprology (2017)
153. Persistent Lip Enlargement: An Unusual Presentation of Lupus Erythematosus, International Journal of Women's Dermatology (2017)
154. Rituximab Administration in a Patient With Pemphigus Vulgaris Following Reactivation of Occult Hepatitis B Virus Infection, Dermatology Online Journal (2017)
155. Skin Cancer: Genetics, Immunology, Treatments, and Psychological Care, Cancer Genetics and Psychotherapy (2017)
156. Superficial Plantar Angiomyxoma in a Young Man, Australasian Journal of Dermatology (2017)
157. Blockage of T Cell Activation Via Anti-Cd40 and Anti-Cd154 Monoclonal Antibodies Can Possibility Treat Alopecia Areata, Scandinavian Journal of Immunology (2016)
158. Complex Interaction Between Diphenylcyclopropenone and Immune Responses in Alopecia Areata, Scandinavian Journal of Immunology (2016)
159. The Dual Nature of Retinoic Acid in Pemphigus and Its Therapeutic Potential: Special Focus on All-Trans Retinoic Acid, International Immunopharmacology (2016)
160. Loss of Normal Anagen Hair in Pemphigus Vulgaris, Clinical and Experimental Dermatology (2015)